CASP9 and central nervous system cancer: Gefitinib has been reported to induce apoptosis in glioma cells by activating the pro-apoptotic protein Bad, with the ensuing mitochondrial translocation of Bax and the activation of caspase-9, which activates caspase-3 [214].